modafinil has been researched along with phenylalanine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Baez, S; Jimenez, V; John, E; Lechin, F; Lechin, ME; Orozco, B; Pardey-Maldonado, B; van der Dijs, B | 1 |
| Ahnaou, A; Drinkenburg, W; Franken, P; Hasan, S; Pradervand, S; Tafti, M | 1 |
| Javaheri, S | 1 |
| Cavalli, F; Franceschini, C; Pizza, F; Plazzi, G | 1 |
| Bron, M; Bujanover, S; Kratochvil, D; Lucas, E; Menno, D; Patel, D; Ronnebaum, S; Stepnowsky, C | 1 |
| Belliard, S; Berrebi-Bertrand, I; Finance, O; Giret, M; Krief, S; Lecomte, JM; Ligneau, X; Nagmar, I; Perrin, D; Robert, P; Schwartz, JC; Uguen, M | 1 |
3 review(s) available for modafinil and phenylalanine
| Article | Year |
|---|---|
Update on Persistent Excessive Daytime Sleepiness in OSA.
Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Modafinil; Phenylalanine; Piperidines; Sleep Apnea, Obstructive; Wakefulness-Promoting Agents | 2020 |
A practical guide to the pharmacological and behavioral therapy of Narcolepsy.
Topics: Behavior Therapy; Carbamates; Counseling; Humans; Modafinil; Narcolepsy; Phenylalanine; Piperidines; Wakefulness-Promoting Agents | 2021 |
Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
Topics: Benzhydryl Compounds; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Modafinil; Phenylalanine; Sleep Apnea, Obstructive; Treatment Outcome | 2021 |
1 trial(s) available for modafinil and phenylalanine
| Article | Year |
|---|---|
Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Aged; Benzhydryl Compounds; Buspirone; Desipramine; Drug Therapy, Combination; Electromyography; Epinephrine; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Modafinil; Myasthenia Gravis; Neuroprotective Agents; Neurotransmitter Agents; Norepinephrine; Phenylalanine; Platelet Aggregation; Propranolol; Serotonin; Serotonin Receptor Agonists; Sympathetic Nervous System; Tyrosine | 2000 |
2 other study(ies) available for modafinil and phenylalanine
| Article | Year |
|---|---|
How to keep the brain awake? The complex molecular pharmacogenetics of wake promotion.
Topics: Animals; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Gene Expression Regulation; Genotype; Male; Mice; Mice, Inbred Strains; Modafinil; Nerve Tissue Proteins; Pharmacogenetics; Phenylalanine; Proto-Oncogene Proteins c-fos; Sleep; Species Specificity; Spectrum Analysis; Statistics as Topic; Time Factors; Wakefulness | 2009 |
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corpus Striatum; Disorders of Excessive Somnolence; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Drug Inverse Agonism; Feeding Behavior; Histamine Antagonists; Locomotion; Mice; Modafinil; Narcolepsy; Neostriatum; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Phenylalanine; Piperidines; Receptors, Histamine H3; Sleep Apnea, Obstructive; Wakefulness-Promoting Agents | 2021 |